The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows (in thousands): (Details) - Upsher-Smith Laboratories, LLC [Member] $ in Thousands |
Jun. 30, 2023
USD ($)
|
---|---|
Business Acquisition [Line Items] | |
Fair Value | $ 10,100 |
Developed technology - Tosymra [Member] | |
Business Acquisition [Line Items] | |
Fair Value | $ 3,400 |
Useful Life (years) | 8 years |
Developed technology - Zembrace [Member] | |
Business Acquisition [Line Items] | |
Fair Value | $ 6,700 |
Useful Life (years) | 13 years |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|